Winselow Tucker
September 13, 2021
Reflecting on our leadership in blood cancer: a Q&A with Winselow Tucker >
BMS supports Light the Night event
July 20, 2021
Why support of Light The Night is ‘at the heart of Bristol Myers Squibb’ >
Evolving Needs of People with Beta Thalassemia
June 03, 2021
Evolving Needs of People with Beta Thalassemia >
Bristol Myers Squibb researchers conducting a lab tour in 2019
March 22, 2021
Multiple myeloma action month: innovation and research >
Patients have a single goal: The best care possible. But too often African American patients with multiple myeloma aren’t getting it
January 14, 2021
Patients have a single goal: The best care possible. But too often African American patients with multiple myeloma aren’t getting it >
Team BMS surpasses fundraising goal for Light The Night
December 18, 2020
Team BMS surpasses fundraising goal for Light The Night >
In Cellular Therapy, Patients and Physicians are Always Learning
December 01, 2020
In Cellular Therapy, Patients and Physicians Are Always Learning >
Cell Therapy: Looking to the Future of CAR T
November 11, 2020
Looking to the Future of Cell Therapy >
Improving Patients’ Lives Through Cell Therapy Research and Development – Kristen Hege
September 24, 2020
Improving Patients’ Lives Through Cell Therapy Research and Development – Kristen Hege >
Raising Awareness about Blood Cancers: A Diverse and Complex Group of Diseases
August 31, 2020
Raising Awareness about Blood Cancers: A Diverse and Complex Group of Diseases >
December 05, 2019
Growing up with beta-thalassemia: Taking charge of your care >
Understanding the Complexities of a Myelofibrosis Diagnosis
October 18, 2019
Understanding the Complexities of a Myelofibrosis Diagnosis >